Elangovan H et al. recently published a review summarizing the role of vitamin D in liver diseases, with a particular focus on vitamin D supplementation in hepatopathies. In the section on Clinical studies in non-alcoholic fatty liver disease (6.3), among others, the authors commented the monocentric, randomized, double blind, placebo controlled trial which we conducted on 55 patients with type 2 diabetes and NAFLD (number 2011-003010-17, www.clinicaltrialsregister.eu) at Sapienza University of Rome, Italy.
Comment on Elangovan H et al. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916 / Barchetta, Ilaria; DEL BEN, Maria; Angelico, Francesco; DI MARTINO, Michele; Fraioli, Antonio; LA TORRE, Giuseppe; Saulle, Rosella; Perri, L; Morini, S; Tiberti, Claudio; Bertoccini, Laura; Cimini, F. A; Panimolle, Francesca; Catalano, Carlo; Baroni, Marco Giorgio; Cavallo, Maria Gisella. - In: BIOCHIMICA ET BIOPHYSICA ACTA. - ISSN 0006-3002. - 1863:9(2017). [10.1016/j.bbadis.2017.04.023]
Comment on Elangovan H et al. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916
BARCHETTA, ILARIAPrimo
;DEL BEN, MariaSecondo
;ANGELICO, Francesco;DI MARTINO, MICHELE;FRAIOLI, Antonio;LA TORRE, Giuseppe;SAULLE, ROSELLA;TIBERTI, Claudio;BERTOCCINI, LAURA;PANIMOLLE, FRANCESCA;CATALANO, Carlo;BARONI, Marco GiorgioPenultimo
;CAVALLO, Maria GisellaUltimo
2017
Abstract
Elangovan H et al. recently published a review summarizing the role of vitamin D in liver diseases, with a particular focus on vitamin D supplementation in hepatopathies. In the section on Clinical studies in non-alcoholic fatty liver disease (6.3), among others, the authors commented the monocentric, randomized, double blind, placebo controlled trial which we conducted on 55 patients with type 2 diabetes and NAFLD (number 2011-003010-17, www.clinicaltrialsregister.eu) at Sapienza University of Rome, Italy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Barchetta_Comment-on-Elangovan-H_2017.pdf
solo gestori archivio
Note: Comment on Elangovan H et al. Vitamin D in liver disease- Current evidence and potential directions. Biochim Biophys Acta 2017
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Altra licenza (allegare)
Dimensione
100.85 kB
Formato
Adobe PDF
|
100.85 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
